The results of VCO clinical trials were expected to be released by the 2nd week of November, according to DOST.
The Department of Science and Technology (DOST) on Saturday said that the results of the clinical trials on the efficacy of virgin coconut oil (VCO) against COVID-19 were expected to be released on the second week of November.
This, as DOST Secretary Fortunato dela Peña said in an interview on GMA Network’s Dobol B sa News TV that they started analyzing the data and the results of clinical trial for virgin coconut oil were expected to release on the second week of November.
Earlier, the Department of Science and Technology aimed to have 45 participating patients who would have virgin coconut oil mixed into their meals and another 45 participating patients without virgin coconut oil in order for researchers to compare the results.
Dela Peña said that their hope was that those who accelerated recovery were the ones given by the virgin coconut oil as the virgin coconut oil had no harmful effects.
Dela Peña also reported that admission of severe coronavirus cases at the Philippine General Hospital had decreased amidst the ongoing clinical trials of Lagundi as a supplemental treatment.
It was last June 3 when the PGH ethics board of the University of the Philippines-Manila approved the inclusion of several COVID-19 patients in clinical trials for virgin coconut oil (VCO).
On October 9, the Department of Science and Technology announced that the clinical trials for lagundi as a medicine to prevent severe coronavirus cases had began.